[HTML][HTML] Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19
J Sun, ZD Yang, X **e, L Li, HS Zeng… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The purpose of this study was to investigate the clinical application of severe acute
respiratory distress syndrome coronavirus-2 (SARS-CoV-2) specific antibody detection and …
respiratory distress syndrome coronavirus-2 (SARS-CoV-2) specific antibody detection and …
[HTML][HTML] Predictive potential of SARS-CoV-2 RNA concentration in wastewater to assess the dynamics of COVID-19 clinical outcomes and infections
RS López-Peñalver, R Cañas-Cañas… - Science of The Total …, 2023 - Elsevier
Coronavirus disease 2019-caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)-, has triggered a worldwide pandemic resulting in 665 million infections and …
(SARS-CoV-2)-, has triggered a worldwide pandemic resulting in 665 million infections and …
Innate immune response in COVID-19: single-cell multi-omics profile of NK lymphocytes in a clinical case series
S Barbon, F Armellin, V Passerini, S De Angeli… - Cell Communication and …, 2024 - Springer
Background COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome-
Coronavirus-2 (SARS-CoV-2) represents the biggest global health emergency in recent …
Coronavirus-2 (SARS-CoV-2) represents the biggest global health emergency in recent …
Antibody response after the third SARS-CoV-2 vaccine in solid organ transplant recipients and people living with HIV (COVERALL-2)
Background After basic immunization with 2 mRNA SARS-CoV-2 vaccine doses, only a
small proportion of patients who are severely immunocompromised generate a sufficient …
small proportion of patients who are severely immunocompromised generate a sufficient …
Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals
HHM da Costa, VO Silva, GC Amorim… - Journal of …, 2024 - Elsevier
The study evoluated an in-house Spike Receptor Binding Domain Enzyme-Linked
Immunosorbent Assay (RBD-IgG-ELISA) for detecting SARS-CoV-2 IgG antibodies in …
Immunosorbent Assay (RBD-IgG-ELISA) for detecting SARS-CoV-2 IgG antibodies in …
Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort
S Nurisyah, M Iyori, AA Hasyim, A Sakamoto… - Antibodies, 2023 - mdpi.com
Background: To fight the COVID-19 pandemic, immunity against SARS-CoV-2 should be
achieved not only through natural infection but also by vaccination. The effect of COVID-19 …
achieved not only through natural infection but also by vaccination. The effect of COVID-19 …
[PDF][PDF] Letter to the Editor Regarding" Evaluation of SARS-CoV-2 Specific Antibodies in Recovered Patients by Different ELISA Kits"
NA Deshpande - Iranian Journal of Immunology, 2023 - iji.sums.ac.ir
I read your research paper “Evaluation of SARS-CoV-2 Specific Antibodies in Recovered
Patients by Different ELISA Kits” with great interest (1). Your study offers significant insights …
Patients by Different ELISA Kits” with great interest (1). Your study offers significant insights …
An Updated Overview of Coronavirus Disease 2019
Coronaviruses have been present for decades but garnered a renewed interest in the past
20 years after the SARS, MERS, and COVID-19 outbreaks. A substantial amount of progress …
20 years after the SARS, MERS, and COVID-19 outbreaks. A substantial amount of progress …
Development of an Aptamer-functionalized Magnetic Particle Sample Purification Protocol for the Plasmonic Polymerase Chain Reaction Diagnosis of Severe Acute …
A Resendes - 2024 - escholarship.mcgill.ca
Background Despite having endured numerous pandemics throughout history and working
with 21st century technology, the world was still unprepared to deal with the emergence of …
with 21st century technology, the world was still unprepared to deal with the emergence of …